A new study in JAMA Cardiology uncovered a set of genetic variants that are almost exclusive to people of African ancestry and may explain their higher risk of adverse events related to dilated cardiomyopathy (DCM).

The FDA on Aug. 17 sent a letter warning cardiologists about high mortality and stroke rates associated with the Temporary Total Artificial Heart (TAH-t) Companion 2 Driver System during a post-approval study.

Originally thought to be a benign condition, Takotsubo syndrome is associated with long-term outcomes similar to acute coronary syndrome (ACS), researchers reported in the Journal of the American College of Cardiology. And in cases where Takotsubo syndrome (TTS) is triggered by physical events, prognosis is even worse.

Japanese researchers believe they’ve identified a genetic risk marker that could pinpoint which people with atrial fibrillation (AFib) are at risk of developing tachycardia-induced cardiomyopathy.

Home-delivered sodium-restricted Dietary Approaches to Stop Hypertension (DASH/SRD) meals after heart failure (HF) hospitalizations appeared safe in some patients, has the potential to improve HF symptoms and can reduce readmissions, according to new research in Circulation: Heart Failure.

In a single-center study of smokers with heart failure, those who also had emphysema identified by CT were twice as likely to be rehospitalized for heart failure in the following two years.

While heart failure (HF) is an uncommon complication of breast cancer, a new study in the Journal of the American College of Cardiology notes individuals treated with trastuzumab-based chemotherapy have a higher risk for HF—but they are not monitored for it, despite recommendations.

A program designed to provide rapid follow-up visits to heart failure patients after hospital discharge improved 30-day survival, reduced readmissions and saved money, according to a retrospective study published in the American Journal of Medical Quality.